Mary Ann Isaacs
Overview
Explore the profile of Mary Ann Isaacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
90
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stein B, Williams D, Rogers O, Isaacs M, Spivak J, Moliterno A
Exp Hematol
. 2010 Oct;
39(1):95-101.
PMID: 20888389
Objective: Suppression of normal hematopoiesis by the neoplastic clone (clonal dominance) is a feature of the myeloproliferative neoplasms, but the determinants that predict clonal dominance are unknown. The objective of...
2.
Stein B, Williams D, Wang N, Rogers O, Isaacs M, Pemmaraju N, et al.
Haematologica
. 2010 Feb;
95(7):1090-7.
PMID: 20133898
Background: The JAK2(V617F) allele burden is a variable measure, determined by the frequency of mitotic recombination events and the expansion of JAK2(V617F) clones. Since variability in the JAK2(V617F) allele burden...
3.
Moliterno A, Williams D, Rogers O, Isaacs M, Spivak J
Exp Hematol
. 2008 Aug;
36(11):1480-6.
PMID: 18723264
Objective: The myeloproliferative disorders (MPD), polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF), differ phenotypically, but share the same JAK2(V617F) mutation. We examined the relationship of the quantitative...